| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Julie K Johnson, Alexander Colb. History of Cannabis Regulation and Medicinal Therapeutics: It's Complicated. Clinical therapeutics. vol 45. issue 6. 2023-07-06. PMID:37414502. |
from its origins as a therapeutic agent in 2800 bc china, to the current knowledge on cannabinoids and the cannabinoid system, to the complex status of cannabis regulation across continents-knowledge gained from the history of cannabis use can inform research on cannabis-based treatments for patients with medical conditions that remain challenging in 21st century medicine, warranting research and evidence-based policy options. |
2023-07-06 |
2023-08-14 |
Not clear |
| Edward Y Liu, Kenneth L McCall, Brian J Pipe. Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients. Medical cannabis and cannabinoids. vol 6. issue 1. 2023-07-05. PMID:37404688. |
this study examined medicaid claims for two fda-approved prescription cannabinoids, dronabinol and cannabidiol, approved in 1985 and 2018, respectively, from 2016-2020 to better understand the pharmacoepidemiologic trends and distribution of these drugs in us medicaid amidst the increasing use of non-pharmaceutical formulations of cannabis. |
2023-07-05 |
2023-08-14 |
Not clear |
| Alannah Miranda, Elizabeth Peek, Sonia Ancoli-Israel, Jared W Young, William Perry, Arpi Minassia. The Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal Studies. Behavioral sleep medicine. 2023-07-04. PMID:37401160. |
the role of cannabis and the endocannabinoid system in sleep regulation and cognition: a review of human and animal studies. |
2023-07-04 |
2023-08-14 |
human |
| Odunayo Anthonia Taiwo, Oluwatosin Adebisi Dosumu, Adewale Segun James, Emmanuel Ifeanyichukwu Ugwor, Oluwafemi Adeleke Ojo, Gabriel Adewunmi Dedeke, Oladipo Ademuyiw. Pre-puberty cannabichromene exposure modulates reproductive function via alteration of spermatogenesis, steroidogenesis, and eNOS pathway metabolites. Toxicology reports. vol 10. 2023-07-03. PMID:37396845. |
cannabis and cannabinoids affect almost every system of the body and exert systemic effects such as alterations in memory and cognitive functions, neurotransmission impediment, as well as obstruction of endocrine and reproductive system functions. |
2023-07-03 |
2023-08-14 |
Not clear |
| Nicolás Fernández, Marcello Gian Cappello, Patricia Noemí Quirog. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Forensic science international. vol 349. 2023-07-01. PMID:37392612. |
an assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in argentina. |
2023-07-01 |
2023-08-14 |
Not clear |
| Nicolás Fernández, Marcello Gian Cappello, Patricia Noemí Quirog. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Forensic science international. vol 349. 2023-07-01. PMID:37392612. |
in recent years, the therapeutic use of cannabis products, especially cannabis oils, has increased significantly, due to the pharmacological potential of their cannabinoids, for the treatment of conditions, such as pain management, cancer, and epilepsy. |
2023-07-01 |
2023-08-14 |
Not clear |
| Zhe Yang, Jian-Xia Lyu, Yi-di Wu, Li-Wei Jiang, Dong-Mei L. [Simultaneous determination of five indole/indazole amide-based synthetic cannabinoids in electronic cigarette oil by ultra performance liquid chromatography]. Se pu = Chinese journal of chromatography. vol 41. issue 7. 2023-06-30. PMID:37387281. |
synthetic cannabinoids (scs), which are considered some of the most widely abused new psychoactive substances available today, are much more potent than natural cannabis and display greater efficacy. |
2023-06-30 |
2023-08-14 |
Not clear |
| Rachel S Wightman, Jane Metrik, Timmy R Lin, Alexandra B Collins, Francesca L Beaudoi. Cannabinoid hyperemesis syndrome: clinical trajectories and patterns of use three months following a visit to the emergency department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023-06-30. PMID:37387520. |
cannabinoid hyperemesis syndrome (chs) is a clinical condition of cyclic vomiting, nausea, and abdominal pain associated with chronic cannabis use. |
2023-06-30 |
2023-08-14 |
Not clear |
| Douglas da Silva Rodrigues, Adria Santos Bastos Soares, Claudia Dizioli Franco Buen. The use of cannabinoids in children with epilepsy: A systematic review. Epilepsy & behavior : E&B. vol 145. 2023-06-30. PMID:37390729. |
cannabinoids, especially cannabidiol, began to be studied to contribute to the treatment of these syndromes, configuring an expanding research area. |
2023-06-30 |
2023-08-14 |
Not clear |
| Alice Zucchi, Elisa Innocenzi, Angelo Onorato, Susanna Dolci, Ambra Colopi, Carmela Rita Balistreri, Paola Grimald. PRENATAL EXPOSURE TO CB Mechanisms of ageing and development. 2023-06-29. PMID:37385302. |
the biological effects of cannabis are mediated by two cannabinoid receptors, cb |
2023-06-29 |
2023-08-14 |
Not clear |
| Eric R Larson, Alexandra B Moussa-Tooks, Rachel L Tullar, Amanda R Bolbecker, Brian F O'Donnell, William P Hetrick, Krista M Wisne. Sex differences in neuroendocrine, sympathetic nervous system, and affect responses to acute stress in cannabis users. Psychopharmacology. 2023-06-27. PMID:37367968. |
however, the role of biological sex in this interaction between cannabis use and stress is poorly understood, despite sex differences in neurobiological stress responsivity, endocannabinoid signaling, and clinical correlates of cannabis use. |
2023-06-27 |
2023-08-14 |
Not clear |
| Jack Wilson, Katherine L Mills, Matthew Sunderland, Tom P Freeman, Maree Teesson, Paul S Haber, Christina Mare. Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence. International journal of mental health and addiction. 2023-06-26. PMID:37363767. |
co-occurring cannabis use is common among those with opioid use disorder (oud), but the extent to which it is harmful may be due to its preparation and concentration of various cannabinoids. |
2023-06-26 |
2023-08-14 |
human |
| Toula Kourgiantakis, Eunjung Lee, A Kumsal Tekirdag Kosar, Christine Tait, Carrie K Y Lau, Sandra McNeil, Shelley Craig, Rachelle Ashcroft, Charmaine C Williams, Abby L Goldstein, Uppala Chandrasekera, Deepy Sur, J L Henderso. Youth cannabis use in Canada post-legalization: service providers' perceptions, practices, and recommendations. Substance abuse treatment, prevention, and policy. vol 18. issue 1. 2023-06-22. PMID:37349741. |
youth cannabis use is associated with various adverse effects including psychosis, anxiety, depression, suicidality, respiratory distress, cannabinoid hyperemesis syndrome, and intoxications. |
2023-06-22 |
2023-08-14 |
Not clear |
| Hassaan Iftikhar, Maryam Saleem, Hafiz S Naeem, Dania Fatim. Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review. Cureus. vol 15. issue 5. 2023-06-20. PMID:37337483. |
the use of synthetic cannabinoids and marijuana has been known to be associated with myocardial infarction and coronary vasospasms according to a few case reports published for the pediatric population. |
2023-06-20 |
2023-08-14 |
Not clear |
| Graham Grogan, Kristen Stephens, Jesse Chou, Michael P Timko, Patrick Cottler, Brent R DeGeorg. The Mechanism of Cannabichromene and Cannabidiol Alone Versus in Combination in the Alleviation of Arthritis-Related Inflammation. Annals of plastic surgery. vol 90. issue 6S Suppl 4. 2023-06-19. PMID:37332213. |
cannabidiol (cbd) and cannabichromene (cbc) are minor cannabinoids with reported analgesic and anti-inflammatory properties and have been implicated as potential therapeutics for arthritis-related pain. |
2023-06-19 |
2023-08-14 |
Not clear |
| Heather Barkholtz, Maia Bate. Measuring the diversity gap of cannabis clinical trial participants compared to people who report using cannabis. Scientific reports. vol 13. issue 1. 2023-06-16. PMID:37328519. |
to understand if these population subgroups are represented in cannabis clinical trials, participant demographics were extracted from peer-reviewed clinical trials reporting on pharmacokinetic and/or pharmacodynamic models of cannabis or cannabinoids. |
2023-06-16 |
2023-08-14 |
human |
| Carole M Lindsay, Khalia K Bernard, Amanda M Hammond, Sheldon Beckford, Wendel D Abel, Paul D Brown, Lauriann E Youn. Potency trends of cannabis in Jamaica during the period of 2014 to 2020. Drug testing and analysis. 2023-06-13. PMID:37309060. |
cannabinoids are the terpeno-phenolic compounds found in the cannabis plant and are responsible for its pharmacological activity. |
2023-06-13 |
2023-08-14 |
Not clear |
| Santiago Gómez Velásquez, Ángela María Amaya Heredia, Santiago Bedoya Moncada, Juan Esteban Patiño González, Jorge Ariel Martínez Ramíre. [Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population]. Salud colectiva. vol 19. 2023-06-13. PMID:37311141. |
[recreational cannabis: profile of cannabinoids present in marijuana samples supplied by the consuming population]. |
2023-06-13 |
2023-08-14 |
Not clear |
| Santiago Gómez Velásquez, Ángela María Amaya Heredia, Santiago Bedoya Moncada, Juan Esteban Patiño González, Jorge Ariel Martínez Ramíre. [Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population]. Salud colectiva. vol 19. 2023-06-13. PMID:37311141. |
tetrahydrocannabinol (thc) was found to be the main constituent of circulating marijuana in medellín, where 67.8% of the samples had a high or higher toxicological range for thc; the foregoing in a context where the deregulated market in practice limits the possibility that consumers have to calibrate or decide the concentration of cannabinoids in their doses. |
2023-06-13 |
2023-08-14 |
Not clear |
| Emily Geraci, Carrie Cake, Kevin M Mulieri, Norman E Fen. Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. vol 28. issue 3. 2023-06-12. PMID:37303765. |
as a result of recent legislative changes allowing for increased access to marijuana products, there have been increasing rates of cannabis abuse among adolescents and subsequent diagnoses of cannabinoid hyperemesis syndrome (chs). |
2023-06-12 |
2023-08-14 |
Not clear |